Articles avec comité de lecture de revues internationales

111 - 

Adjuvant corticosteroids for patients hospitalized with community-acquired pneumonia: is it time?

Matthieu Revest, Gérald Egmann, Anthony Chapron, Stéphane Jouneau, Pierre Tattevin

Journal of Thoracic Disease, 2016, 8 (5), E288--291.

DOI : https://doi.org/10.21037/jtd.2016.03.34

Pubmed : 27162684

 

112 - 

HACEK endocarditis: state-of-the-art

Matthieu Revest, Gérald Egmann, Vincent Cattoir, Pierre Tattevin

Expert Review of Anti-infective Therapy, 2016, 14 (5), 523-530.

DOI : https://doi.org/10.1586/14787210.2016.1164032

Pubmed : 26953488

 

113 - 

Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013–14: Results from the InNHOVE network

M. Rondy, J. Castilla, O. Launay, S. Costanzo, C. Ezpeleta, F. Galtier, K. De Gaetano Donati

Human Vaccines & Immunotherapeutics, 2016, 12 (5), 1217--1224.

DOI : https://doi.org/10.1080/21645515.2015.1126013

Pubmed : 27065000

 

114 - 

Symptomatic and Asymptomatic Neurological Complications of Infective Endocarditis: Impact on Surgical Management and Prognosis

Christine Selton-Suty, François Delahaye, Pierre Tattevin, Claire Federspiel, Vincent Le Moing, Catherine Chirouze, Pierre Nazeyrollas, Véronique Vernet-Garnier, Yvette Bernard, Sidney Chocron, Jean-Francois Obadia, François Alla, Bruno Hoen, Xavier Duval

PLoS ONE, 2016, 11 (7), e0158522.

DOI : https://doi.org/10.1371/journal.pone.0158522

Pubmed : 27400273

 

115 - 

Analysis of the 2015 American and European guidelines for the management of infective endocarditis Analyse des recommandations américaines et européennes de 2015 pour la prise en charge des endocardites infectieuses

Pierre Tattevin, Jean-Luc Mainardi

Analysis of the 2015 American and European guidelines for the management of infective endocarditis. Médecine et Maladies Infectieuses, 2016, 46 (8), 406-410.

DOI : https://doi.org/10.1016/j.medmal.2016.05.008

Pubmed : 27297743

 

116 - 

Therapeutic drug monitoring of ganciclovir in CMV infections: Should we reassess the therapeutic range?

C. Tron, C. Arnoult, C. Leven, P. Fillatre, C. Pronier, M. Revest, M. C. Verdier, E. Bellissant, F Lemaitre

Fundamental & Clinical Pharmacology, 2016, 30, 43.

 

117 - 

Should we fear tubing adsorption of antibacterial drugs in extracorporeal membrane oxygenation? An answer for cephalosporins and carbapenems

Camille Tron, Cyril Leven, Pierre Fillâtre, Nicolas Maillard, Nicolas Nesseler, P. Tattevin, Erwan Flécher, Eric Bellissant, Marie-Clémence Verdier, Florian Lemaitre

Clinical and Experimental Pharmacology and Physiology, 2016, 43 (2), pp.281-283.

DOI : https://doi.org/10.1111/1440-1681.12527

Pubmed : 26667301

 

118 - 

The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia.

Sarah Tubiana, Xavier Duval, François Alla, Christine Selton-Suty, Pierre Tattevin, F. Delahaye, Lionel Piroth, Catherine Chirouze, Jean-Philippe Lavigne, Marie-Line Erpelding, Bruno Hoen, F. Vandenesch, Bernard Iung, Vincent Le Moing

The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia. Journal of Infection, 2016, 72 (5), 544-53.

DOI : https://doi.org/10.1016/j.jinf.2016.02.003

Pubmed : 26916042

 

119 - 

A multifaceted intervention designed to improve medical management of moderate to advanced chronic kidney disease in HIV-infected patients: a cluster randomised trial

Sophie Abgrall, Antoine Rachas, Jérôme Tourret, Corinne Isnard-Bagnis, Eric Billaud, Pierre Tattevin, Dominique Costagliola, Marguerite Guiguet, Pierre Durieux, Fhdh-Anrs Co4

Clinical Infectious Diseases, 2015, 61 (3), 375-384.

DOI : https://doi.org/10.1093/cid/civ310

Pubmed : 25904366

 

120 - 

Heart transplantation as salvage treatment of intractable infective endocarditis

Marie Aymami, Matthieu Revest, Caroline Piau, Céline Chabanne, François Le Gall, Bernard Lelong, Jean-Philippe Verhoye, Christian Michelet, Pierre Tattevin, Erwan Flécher

Clinical Microbiology and Infection, 2015, 21 (4), 371-e1.

DOI : https://doi.org/10.1016/j.cmi.2014.11.027

Pubmed : 25630459